Inspection Record

Isologic Innovative Radiopharmaceuticals of Ontario Limited — Health Canada Inspection Findings

Health CanadaInspected 2025-02-04 9 findingsContamination controlOther quality systemAseptic processing and sterility assuranceStability and storageLabeling and packagingEquipment and facility

View the regulator's official source The source document is always the basis for judgement.

Findings

1Contamination control

The company did not adequately demonstrate that air-flow patterns did not pose a risk of contamination.

2Other quality system

The written clothing standards for each environmental grade were inadequate.

3Aseptic processing and sterility assurance

The validation of aseptic processing was inadequate. The aseptic process simulation study was not long enough to cover all routine manipulations, normal interventions, and worst case situations.

4Stability and storage

The temperature and/or humidity control was inadequate.

5Other quality system

The controls were inadequate for creating, modifying, reviewing, storing, and/or retrieving records.

6Labeling and packaging

The importer did not ensure that the foreign sites use to fabricate, package/label, or test drug products met the requirements described in Guidance on Evidence to Demonstrate Drug GMP Compliance of Foreign Sites (GUI-0080).

7Stability and storage

The evidence used to demonstrate the transportation and/or storage conditions of each lot or batch of the drug was inadequate.

8Equipment and facility

Evaluation of production processes, equipment, and/or materials was inadequate. Warning systems did not alert personnel when air pressure fell below established limits.

9Other quality system

The company's visual inspection of filled containers was inadequate.

About this record

Extracted automatically from the document of the Health Canada inspection on 2025-02-04. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

Isologic Innovative Radiopharmaceuticals of Ontario Limited findings history — including this company's other documents Health Canada documents, 2025 Go to Findings search